<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35363404</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2613</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>International journal of experimental pathology</Title><ISOAbbreviation>Int J Exp Pathol</ISOAbbreviation></Journal><ArticleTitle>Transient atrial inflammation in a murine model of Coxsackievirus B3-induced myocarditis.</ArticleTitle><Pagination><StartPage>149</StartPage><EndPage>155</EndPage><MedlinePgn>149-155</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/iep.12438</ELocationID><Abstract><AbstractText>Atrial dysfunction is a relatively common complication of acute myocarditis, although its pathophysiology is unclear. There is limited information on myocarditis-associated histological changes in the atria and how they develop in time. The aim of this study therefore was to investigate inflammation, fibrosis and viral genome in the atria in time after mild CVB3-induced viral myocarditis (VM) in mice. C3H mice (n = 68) were infected with 10<sup>5</sup> PFU of Coxsackievirus B3 (CVB3) and were compared with uninfected mice (n = 10). Atrial tissue was obtained at days 4, 7, 10, 21, 35 or 49 post-infection. Cellular infiltration of CD45+ lymphocytes, MAC3+ macrophages, Ly6G+ neutrophils and mast cells was quantified by (immuno)histochemical staining. The CVB3 RNA was determined by in situ hybridization, and fibrosis was evaluated by elastic van Gieson (EvG) staining. In the atria of VM mice, the numbers of lymphocytes on days 4 and 7 (p &lt; .05) and days 10 (p &lt; .01); macrophages on days 7 (p &lt; .01) and 10 (p &lt; .05); neutrophils on days 4 (p &lt; .05); and mast cells on days 4 and 7 (p &lt; .05) increased significantly compared with control mice and decreased thereafter to basal levels. No cardiomyocyte death was observed, and the CVB3 genome was detected in only one infected mouse on Day 4 post-infection. No significant changes in the amount of atrial fibrosis were found between VM and control mice. A temporary increase in inflammation is induced in the atria in the acute phase of CVB3-induced mild VM, which may facilitate the development of atrial arrhythmia and contractile dysfunction.</AbstractText><CopyrightInformation>© 2022 The Authors. International Journal of Experimental Pathology published by John Wiley &amp; Sons Ltd on behalf of Company of the International Journal of Experimental Pathology (CIJEP).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Linghe</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9419-9011</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Amsterdam University Medical Centers, location AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiet</LastName><ForeName>Mitchell D</ForeName><Initials>MD</Initials><Identifier Source="ORCID">0000-0001-6669-5368</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Amsterdam University Medical Centers, location AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raaijmakers</LastName><ForeName>Daan R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Department of Pathology, Amsterdam University Medical Centers, location AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woudstra</LastName><ForeName>Linde</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Reproductive Medicine, Reinier de Graaf Hospital, Voorburg, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Rossum</LastName><ForeName>Albert C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niessen</LastName><ForeName>Hans W M</ForeName><Initials>HWM</Initials><AffiliationInfo><Affiliation>Department of Pathology, Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Amsterdam University Medical Centers, location AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krijnen</LastName><ForeName>Paul A J</ForeName><Initials>PAJ</Initials><AffiliationInfo><Affiliation>Department of Pathology, Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Amsterdam University Medical Centers, location AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Exp Pathol</MedlineTA><NlmUniqueID>9014042</NlmUniqueID><ISSNLinking>0959-9673</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008809" MajorTopicYN="N">Mice, Inbred C3H</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coxsackievirus B3</Keyword><Keyword MajorTopicYN="N">atria</Keyword><Keyword MajorTopicYN="N">in situ hybridization</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">viral myocarditis</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>1</Day><Hour>12</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35363404</ArticleId><ArticleId IdType="pmc">PMC9264345</ArticleId><ArticleId IdType="doi">10.1111/iep.12438</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Caforio ALP, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636‐2648, 2648a‐2648d.</Citation><ArticleIdList><ArticleId IdType="pubmed">23824828</ArticleId></ArticleIdList></Reference><Reference><Citation>Imazio M, Trinchero R. Myopericarditis: etiology, management, and prognosis. Int J Cardiol. 2008;127:17‐26.</Citation><ArticleIdList><ArticleId IdType="pubmed">18221804</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyake CY, Teele SA, Chen L, et al. In‐hospital arrhythmia development and outcomes in pediatric patients with acute myocarditis. Am J Cardiol. 2014;113:535‐540.</Citation><ArticleIdList><ArticleId IdType="pubmed">24332245</ArticleId></ArticleIdList></Reference><Reference><Citation>Ukena C, Mahfoud F, Kindermann I, Kandolf R, Kindermann M, Bohm M. Prognostic electrocardiographic parameters in patients with suspected myocarditis. Eur J Heart Fail. 2011;13:398‐405.</Citation><ArticleIdList><ArticleId IdType="pubmed">21239404</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrofanova LB, Orshanskaya V, Ho SY, Platonov PG. Histological evidence of inflammatory reaction associated with fibrosis in the atrial and ventricular walls in a case‐control study of patients with history of atrial fibrillation. Europace. 2016;18:iv156‐iv162.</Citation><ArticleIdList><ArticleId IdType="pubmed">28011843</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L, Emmens RW, van Wezenbeek J, et al. Atrial inflammation in different atrial fibrillation subtypes and its relation with clinical risk factors. Clin Res Cardiol. 2020;109:1271‐1281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7515944</ArticleId><ArticleId IdType="pubmed">32072262</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto I, Hagiwara A. Studies on the pathogenesis of atrial myocarditis in mice infected with Coxsackie virus B3. Br J Exp Pathol. 1986;67:43‐53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2013065</ArticleId><ArticleId IdType="pubmed">3947534</ArticleId></ArticleIdList></Reference><Reference><Citation>Begieneman MP, Emmens RW, Rijvers L, et al. Myocardial infarction induces atrial inflammation that can be prevented by C1‐esterase inhibitor. J Clin Pathol. 2016;69:1093‐1099.</Citation><ArticleIdList><ArticleId IdType="pubmed">27153875</ArticleId></ArticleIdList></Reference><Reference><Citation>Baughman KL. Diagnosis of myocarditis: death of Dallas criteria. Circulation. 2006;113:593‐595.</Citation><ArticleIdList><ArticleId IdType="pubmed">16449736</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyto V, Saukko P, Lignitz E, et al. Diagnosis and presentation of fatal myocarditis. Hum Pathol. 2005;36:1003‐1007.</Citation><ArticleIdList><ArticleId IdType="pubmed">16153464</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L, Woudstra L, Dam T, et al. Electrocardiographic changes are strongly correlated with the extent of cardiac inflammation in mice with Coxsackievirus B3‐induced viral myocarditis. Cardiovasc Pathol. 2021;54:107367.</Citation><ArticleIdList><ArticleId IdType="pubmed">34245872</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K, Xu W, Guo Q, et al. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis. Circ Res. 2009;105:353‐364.</Citation><ArticleIdList><ArticleId IdType="pubmed">19608981</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts BJ, Dragon JA, Moussawi M, Huber SA. Sex‐specific signaling through Toll‐Like Receptors 2 and 4 contributes to survival outcome of Coxsackievirus B3 infection in C57Bl/6 mice. Biol Sex Differ. 2012;3:25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3586360</ArticleId><ArticleId IdType="pubmed">23241283</ArticleId></ArticleIdList></Reference><Reference><Citation>Aretz T. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol. 1986;1:3‐14.</Citation><ArticleIdList><ArticleId IdType="pubmed">3455232</ArticleId></ArticleIdList></Reference><Reference><Citation>Begieneman MP, Emmens RW, Rijvers L, et al. Ventricular myocarditis coincides with atrial myocarditis in patients. Cardiovasc Pathol. 2016;25:141‐148.</Citation><ArticleIdList><ArticleId IdType="pubmed">26764148</ArticleId></ArticleIdList></Reference><Reference><Citation>Leiros C, Sterinborda L, Borda E. Lymphocytes infiltration induces dysfunction in autoimmune myocarditis: role of SRS‐A. J Mol Cell Cardiol. 1988;20:149‐158.</Citation><ArticleIdList><ArticleId IdType="pubmed">3260962</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>